Patients treated with Gilenya “show benefits”
Patients treated with Gilenya “show benefits”
New research evaluating Gilenya’s clinical efficacy, safety, and tolerability in patients with relapsing-remitting multiple sclerosis (RRMS) has largely supported its use, finding the oral drug’s efficacy in a real-world setting was comparable to results observed in Phase 3 clinical studies...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
- CureOrBust
- Family Elder
- Posts: 3374
- Joined: Wed Jul 27, 2005 2:00 pm
- Location: Sydney, Australia
Re: Patients treated with Gilenya “show benefits”
So, it basically performs the same as what the much larger Phase 3 clinical trial found, ie no news. I think the manufacturers "spin doctors" had a hand in this to keep Gylenya in the "news" and on the prescription pad...following 105 RRMS patients...
finding the oral drug’s efficacy in a real-world setting was comparable to results observed in Phase 3 clinical studies....
The efficacy and safety results of this study were found to be comparable to those observed in Phase 3 clinical trials...
Sure, its great that it is being monitored, but hardly news.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 5 Replies
- 14863 Views
-
Last post by gibbledygook
-
- 2 Replies
- 1721 Views
-
Last post by NHE
-
- 0 Replies
- 1547 Views
-
Last post by frodo
-
- 0 Replies
- 1552 Views
-
Last post by NHE
-
- 0 Replies
- 2476 Views
-
Last post by frodo